5.24
1.55%
0.08
Coya Therapeutics Inc Azioni (COYA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
97.89%
0.1268
|
6.0022 | - | - | - |
Operating Expenses |
33.98%
5.6098
|
4.1871 | 3.5641 | 3.2543 | 2.9001 |
Benefits Costs and Expenses |
5.1788
|
- | - | - | - |
Costs And Expenses |
5.1788
|
- | - | - | - |
Operating Income/Loss |
402.07%
-5.483
|
1.8152 | -3.5641 | -3.2543 | -2.9001 |
Income/Loss From Continuing Operations Before Tax |
353.89%
-5.0519
|
1.9898 | -3.422 | -3.0954 | -2.7365 |
Income/Loss From Continuing Operations After Tax |
499.05%
-5.0519
|
1.266 | -3.422 | -3.0954 | -2.7365 |
Net Income/Loss
|
499.05%
-5.0519
|
1.266 | -3.422 | -3.0954 | -2.7365 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
4,878%
14.46
|
0.2905 | 9.9479 | 9.9479 | 9.7218 |
Diluted Average Shares |
4,878%
14.46
|
0.2905 | 9.9479 | 9.9479 | 9.7218 |
Basic Earnings Per Share |
333.33%
-0.35
|
0.15 | -0.34 | -0.31 | -0.28 |
Diluted Earnings Per Share |
333.33%
-0.35
|
0.15 | -0.34 | -0.31 | -0.28 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):